Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 4098140, 10 pages
https://doi.org/10.1155/2018/4098140
Research Article

A Nonenzymatic and Automated Closed-Cycle Process for the Isolation of Mesenchymal Stromal Cells in Drug Delivery Applications

1CRC StaMeTec, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
2I.R.C.C.S Galeazzi Orthopedic Institute, Milan, Italy
3Maxillofacial and Dental Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via Commenda 10, 20122 Milan, Italy
4Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
5University Research Center “Integrated Models for Prevention and Protection in Environmental and Occupational Health” (MISTRAL), Brescia, Italy
6Cellular Neurobiology Laboratory, Department of Cerebrovascular Diseases, Fondazione IRCCS Neurological Institute C. Besta, Milan, Italy
7Image Institute, Milan, Italy
8Lipogems International Spa, Milan, Italy
9Hydra srl, Mirandola, Modena, Italy

Correspondence should be addressed to Augusto Pessina; ti.iminu@anissep.otsugua

Received 12 October 2017; Accepted 25 December 2017; Published 20 February 2018

Academic Editor: Massimo Petruzzi

Copyright © 2018 Valentina Coccè et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Caplan, “Adult mesenchymal stem cells for tissue engineering versus regenerative medicine,” Journal of Cellular Physiology, vol. 213, no. 2, pp. 341–347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. I. Caplan, “Why are MSCs therapeutic? New data: new insight,” The Journal of Pathology, vol. 217, no. 2, pp. 318–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Schäffler and C. Büchler, “Concise review: adipose tissue-derived stromal cells—basic and clinical implications for novel cell-based therapies,” Stem Cells, vol. 25, no. 4, pp. 818–827, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Bonomi, V. Coccè, L. Cavicchini et al., “Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity,” International Journal of Immunopathology and Pharmacology, vol. 26, no. Supplement 1, pp. 33–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Pessina, A. Bonomi, V. Coccè et al., “Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy,” PLoS One, vol. 6, no. 12, article e28321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Oberbauer, C. Steffenhagen, C. Wurzer, C. Gabriel, H. Redl, and S. Wolbank, “Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art,” Cell Regeneration, vol. 4, no. 1, p. 4:7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Bellei, E. Migliano, M. Tedesco, S. Caputo, and M. Picardo, “Maximizing non-enzymatic methods for harvesting adipose-derived stem from lipoaspirate: technical considerations and clinical implications for regenerative surgery,” Scientific Reports, vol. 7, no. 1, article 10015, 2017. View at Publisher · View at Google Scholar
  8. F. Bianchi, M. Maioli, E. Leonardi et al., “A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates,” Cell Transplantation, vol. 22, no. 11, pp. 2063–2077, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Tremolada, G. Beltrami, and A. Magri, “Adipose mesenchymal stem cells and “regenerative adipose tissue graft” (LIPOGEMS™) for musculoskeletal regeneration,” European Journal Of Musculoskeletal Disease, vol. 3, no. 2, pp. 57–67, 2014. View at Google Scholar
  10. A. T. Brini, V. Coccè, L. M. Josè Ferreira et al., “Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel,” Expert Opinion on Drug Delivery, vol. 13, no. 6, pp. 1–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Berenzi, N. Steimberg, J. Boniotti, and G. Mazzoleni, “MRT letter: 3D culture of isolated cells: a fast and efficient method for optimizing their histochemical and immunocytochemical analyses,” Microscopy Research and Technique, vol. 78, no. 4, pp. 249–254, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Tropel, D. Noël, N. Platet, P. Legrand, A. L. Benabid, and F. Berger, “Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow,” Experimental Cell Research, vol. 295, no. 2, pp. 395–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bonomi, A. Silini, E. Vertua et al., “Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study,” Stem Cell Research & Therapy, vol. 6, no. 1, p. 155, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Coccè, A. Vitale, S. Colombo et al., “Human skin-derived fibroblasts used as a ‘Trojan horse’ for drug delivery,” Clinical and Experimental Dermatology, vol. 41, no. 4, pp. 417–424, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Pessina, V. Coccè, L. Pascucci et al., “Mesenchymal stromal cells primed with paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice,” British Journal of Haematology, vol. 160, no. 6, pp. 766–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. McIntosh, R. A. Schoumacher, and R. E. Tiller, “Pancreatic adenocarcinoma in a patient with cystic fibrosis,” The American Journal of Medicine, vol. 85, no. 4, p. 592, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Mossman, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  19. L. J. Reed and H. Muench, “A simple method of estimating fifty per cent endpoints,” American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938. View at Publisher · View at Google Scholar
  20. C. Tremolada, V. Colombo, and C. Ventura, “Adipose tissue and mesenchymal stem cells: state of the art and Lipogems® technology development,” Current Stem Cell Reports, vol. 2, no. 3, pp. 304–312, 2016. View at Publisher · View at Google Scholar
  21. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Crisan, S. Yap, L. Casteilla et al., “A perivascular origin for mesenchymal stem cells in multiple human organs,” Cell Stem Cell, vol. 3, no. 3, pp. 301–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Crisan, M. Corselli, W. C. Chen Corselli, C. WCW, and B. Péault, “Perivascular cells for regenerative medicine,” Journal of Cellular and Molecular Medicine, vol. 16, no. 12, pp. 2851–2860, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Ceserani, A. Ferri, A. Berenzi et al., “Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells,” Vascular Cell, vol. 8, no. 1, p. 3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. F. S. Shah, X. Wu, M. Dietrich, J. Rood, and J. M. Gimble, “A non-enzymatic method for isolating human adipose tissue-derived stromal stem cells,” Cytotherapy, vol. 15, no. 8, pp. 979–985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Fekete, M. T. Rojewski, D. Fürst et al., “GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC,” PLoS One, vol. 7, no. 8, article e43255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. L. Torre, E. Lucarelli, S. Guidi et al., “Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application,” Stem Cells and Development, vol. 24, no. 6, pp. 677–685, 2015. View at Publisher · View at Google Scholar · View at Scopus